Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Avantor, Inc.AVTR · Entity 3546 | Director | May 07, 2026 | May 11, 2026 |
| Bruker Cellular Analysis, Inc.CELL · Entity 109250 | Director | October 02, 2023 | October 03, 2023 |
| DENTSPLY SIRONA Inc.XRAY · Entity 4448 | Director | June 03, 2026 | June 05, 2026 |
| MARAVAI LIFESCIENCES HOLDINGS, INC.MRVI · Entity 4291 | Director | June 09, 2026 | June 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Avantor, Inc.
Report date May 07, 2026 · Filed May 11, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,006 |
Reported balance
After 2026-05-07 transaction · row 1
1 source rowRow 1 · 2026-05-07 · Grant · Acquired 25,270 · Balance 34,006 F1: Reflects a grant of restricted stock units that vests on May 7, 2027. |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 60,000 |
Reported balance
After 2026-05-08 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-05-08 · Purchase · Acquired 10,000 · Balance 60,000 F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above. F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects a grant of restricted stock units that vests on May 7, 2027.
F2: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions ranging from $8.30 to $8.32, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth above.
F3: By a trust of which the reporting person serves as trustee and is a beneficiary. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Bruker Cellular Analysis, Inc.
Report date October 02, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 136,062 |
Reported balance
After 2023-10-02 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2023-10-02 · Exercise / conversion · Disposed 70,000 · Balance 136,062 F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration"). F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration. |
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 0 |
Reported balance
After 2023-10-02 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2023-10-02 · Disposition to issuer · Disposed 136,062 · Balance 0 F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration. F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 2, 2023, pursuant to the Agreement and Plan of Merger dated as of August 17, 2023 (the "Merger Agreement"), by and among Bruker Corporation ("Bruker"), Bird Mergersub Corporation ("Merger Sub") and Phenomex Inc. (the "Company"), Merger Sub merged with and into the Company, with the Company surviving the Merger as a wholly owned subsidiary of Bruker (the "Merger"), and each restricted stock unit ("RSU") held by the Reporting Person was cancelled and converted into the right to receive $1.00 per share in cash (the "Merger Consideration").
F2: Pursuant to the Merger, the Reporting Person disposed of each RSU held by him in exchange for the Merger Consideration.
F3: Pursuant to the Merger Agreement, each outstanding share of Common Stock, par value $0.00005 per share ("Common Stock") held by the Reporting Person was cancelled and converted into the right to receive the "Merger Consideration.
F4: Pursuant to the Merger, the Reporting Person disposed of all shares of Common Stock beneficially owned by him in exchange for the Merger Consideration.
DENTSPLY SIRONA Inc.
Report date June 03, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2026-06-03 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-03 · Grant · Acquired 38,382 · Balance 38,382 F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Row 2 · 2026-06-03 · Gift · Disposed 38,382 · Balance 0 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 63,283.284 |
Reported balance
After 2026-06-03 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-06-03 · Gift · Acquired 38,382 · Balance 63,283.284 F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 10,900 |
Reported balance
After 2026-06-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-06-03 · Grant · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2036-06-03 | Direct | 0 |
Reported balance
After 2026-06-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-06-03 · Gift · Disposed 10,900 · Balance 0 F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. F3: Stock Options vest in full one (1) year from date of grant. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $9.64 · Expires 2026-06-05 | IndirectBy Family Partnership | 10,900 |
Reported balance
After 2026-06-03 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-06-03 · Gift · Acquired 10,900 · Balance 10,900 F3: Stock Options vest in full one (1) year from date of grant. F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs. |
| Common StockSEC Table I · non-derivative | IndirectBy Gregory Lucier IRA | 21,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 21,000 |
| Common StockSEC Table I · non-derivative | IndirectBy a Trust | 65,000 |
Reported balance
Holding disclosure · report date 2026-06-03 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 65,000 |
Filing footnotes · ownership attribution and instrument terms
F1: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant.
F2: Represents RSUs gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such RSUs. The reporting person disclaims beneficial ownership of these RSUs except to the extent of his pecuniary interest therein, and the inclusion of these RSUs in this report shall not be an admission that the reporting person is the beneficial owner of the RSUs for purposes of Section 16 of the Exchange Act or for any other purpose.
F3: Stock Options vest in full one (1) year from date of grant.
F4: Represents Non-Qualified Stock Options (NQSOs) gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such NQSOs.
MARAVAI LIFESCIENCES HOLDINGS, INC.
Report date June 09, 2026 · Filed June 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 155,123 |
Reported balance
After 2026-06-09 transaction · row 1
1 source rowRow 1 · 2026-06-09 · Gift · Disposed 46,293 · Balance 155,123 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Family Partnership | 156,077 |
Reported balance
After 2026-06-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-06-09 · Gift · Acquired 46,293 · Balance 156,077 F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares gifted by the Reporting Person to a family partnership, the partners of which include a trust for the benefit of the reporting person. The reporting person's spouse serves as the general partner of the partnership, and in such capacity, may have voting and dispositive power over all of such shares. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be an admission that the reporting person is the beneficial owner of the shares for purposes of Section 16 of the Exchange Act or for any other purpose.
Past disclosures · reporting ended (3)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Catalent, Inc.
Report date December 18, 2024 · Filed December 18, 2024
Section 16 reporting ended · disclosed 2024-12-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2024-12-18 transaction · row 1
1 source rowRow 1 · 2024-12-18 · Disposition to issuer · Disposed 36,914 · Balance 0 F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger"). F2: Includes restricted stock units ("RSUs"). F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration"). F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms. |
Filing footnotes · ownership attribution and instrument terms
F1: On December 18, 2024, Creek Parent, Inc., a Delaware corporation ("Parent"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Parent and Creek Merger Sub, Inc., a Delaware corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), dated as of February 5, 2024 (the "Merger Agreement"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Parent (the "Merger").
F2: Includes restricted stock units ("RSUs").
F3: At the effective time of the Merger (the "Effective Time"), each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $63.50 in cash, without interest (the "Merger Consideration").
F4: At the Effective Time, each RSU, whether or not vested, outstanding immediately prior to the Effective Time vested (if unvested) and was cancelled and converted into the right to receive an amount in cash, without interest, equal to the product of (i) the total number of shares of Issuer common stock subject to the RSU multiplied by (ii) the Merger Consideration, except for certain RSUs granted following the date of the Merger Agreement which were converted at the Effective Time into restricted cash awards equal to the product of (a) the Merger Consideration multiplied by (b) the number of shares of Issuer common stock subject to such award and otherwise remain subject to their terms, including vesting and acceleration terms.
Invuity, Inc.
Report date October 23, 2018 · Filed October 23, 2018
Section 16 reporting ended · disclosed 2018-10-23. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2018-10-23 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-10-23 · Disposition to issuer · Disposed 99,219 · Balance 52,231 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Row 2 · 2018-10-23 · Disposition to issuer · Disposed 52,231 · Balance 0 F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. |
| Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2018-10-23 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2018-10-23 · Disposition to issuer · Disposed 18,245 · Balance 0 F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.15 · Expires 2024-01-21 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2018-10-23 · Disposition to issuer · Disposed 24,648 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.87 · Expires 2021-05-19 | Direct | 0 |
Reported balance
After 2018-10-23 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-10-23 · Disposition to issuer · Disposed 28,900 · Balance 0 F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price").
F2: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock.
F3: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price.
F4: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member.
F5: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option.
NUVASIVE INC
Report date May 18, 2021 · Filed May 20, 2021
Section 16 reporting ended · disclosed 2021-05-20. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectFamily Trust | 257,939 |
Last balance in matching sequence
After 2021-05-18 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2021-05-18 · Exercise / conversion · Acquired 19,125 · Balance 266,344 F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired. F2: Shares indirectly held by the Reporting Person. Row 2 · 2021-05-18 · Tax withholding · Disposed 8,405 · Balance 257,939 F3: Shares withheld by the Issuer to satisfy tax withholding obligations. F2: Shares indirectly held by the Reporting Person. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-05-18 · Exercise / conversion · Disposed 8,312 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-05-18 · Exercise / conversion · Disposed 1,416 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-05-18 · Exercise / conversion · Disposed 3,725 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-05-18 · Exercise / conversion · Disposed 2,577 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested. |
| RSUsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-05-18 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-05-18 · Exercise / conversion · Disposed 3,095 · Balance 0 F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 18, 2021, the Reporting Person retired from his position as a member of the Issuer's Board of Directors. Pursuant to deferral elections made by the Reporting Person, all shares underlying Restricted Stock Units ("RSUs") subject to such deferrals will be delivered to the Reporting Person promptly following May 18, 2021, the date on which the Reporting Person retired.
F2: Shares indirectly held by the Reporting Person.
F3: Shares withheld by the Issuer to satisfy tax withholding obligations.
F4: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.
F5: This RSU award was granted to the Reporting Person on December 4, 2013 and is fully vested.
F6: This RSU award was granted to the Reporting Person on May 22, 2014 and is fully vested.
F7: This RSU award was granted to the Reporting Person on May 9, 2019 and is fully vested.
F8: This RSU award was granted to the Reporting Person on May 28, 2020 and is fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 19, 2020 Filed Nov 23, 2020 22:36 UTC | MARAVAI LIFESCIENCES HOLDINGS, INC. MRVI · Entity 4291 | GrantClass A Common Stock | 11,852 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-20-031954 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,852 Read SEC document |
| October 29, 2020 Filed Nov 2, 2020 12:22 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000215 · wf-form4_160431968597692.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,707 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur on the earlier of one year from the date of award and the date of the Issuer's fiscal 2021 annual meeting of shareholders. F2 · balance_after: Includes restricted stock units. Read SEC document |
| October 09, 2020 Filed Oct 13, 2020 19:38 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11.015 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-026851 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,098.795 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| August 27, 2020 Filed Aug 28, 2020 22:47 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 661 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-20-000145 · wf-form4_159865483862200.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,582 F1 · kind: The equity acquired by the reporting person is part of the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. The grant is in respect of the period between July 1, 2020 and the date of the reporting person's annual meeting of shareholders in respect of fiscal 2020. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 30, 2020 Filed Aug 3, 2020 16:02 UTC | Catalent, Inc. CTLT · Entity 16279 | SaleCommon Stock | 24,000 | $90.09 | $2,162,160.00 |
DisclosureSEC source: 0001596783-20-000118 · wf-form4_159647051902115.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,921 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification. F2 · price: Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.17, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · balance_after: Includes restricted stock units. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:48 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | GrantStock Option · Derivative | 125,000 | $0.00 Strike: $22.00 | $0.00 |
DisclosureSEC source: 0000899243-20-019736 · doc4.xml · derivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2030-06-25 F1 · derivative.exercise_date: The stock option shall vest in equally monthly installments beginning on [the grant date] until fully vested on June 25, 2024. Read SEC document |
| July 16, 2020 Filed Jul 20, 2020 21:48 UTC | Bruker Cellular Analysis, Inc. BLI · Entity 109250 | PurchaseCommon Stock | 22,727 | $22.00 | $499,994.00 |
DisclosureSEC source: 0000899243-20-019734 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Lucier Family Trust Disclosed balance after: 22,727 F1 · ownership.nature: As trustee of the Lucier Family Trust (the "Trust"), Mr. Lucier may be deemed to beneficially own the shares held by the Trust. Mr. Lucier disclaims beneficial ownership of the shares held by the Trust except to the extent of his pecuniary interest therein. Read SEC document |
| July 10, 2020 Filed Jul 10, 2020 20:57 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 11.053 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021353 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,087.78 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 28, 2020 Filed May 29, 2020 17:54 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantRSUs · Derivative | 3,095 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033004 · doc4.xml · derivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,095 Underlying: Common Stock · 3,095 shares Expires not disclosed F1 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors. F2 · derivative.expiration_date: Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2021 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors. Read SEC document |
| May 21, 2020 Filed May 22, 2020 20:20 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4,766 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-017764 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,076.727 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| April 10, 2020 Filed Apr 14, 2020 20:18 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 37.93 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-013699 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,310.727 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 33,695 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015506 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,695 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the PRSU award, the award vested as to 33,695 shares on March 1, 2020. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2017. In accordance with the terms of the PRSU award, the award vested as to 33,695 shares on March 1, 2020. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 14,547 | $65.81 | $957,338.07 |
DisclosureSEC source: 0001209191-20-015506 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 221,368 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| March 01, 2020 Filed Mar 3, 2020 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 33,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-015506 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 235,915 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| February 13, 2020 Filed Feb 14, 2020 19:43 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 2,000 | $59.71 | $119,420.00 |
DisclosureSEC source: 0001596783-20-000021 · wf-form4_158170937932187.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,921 F1 · price: Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $59.60 to $59.82, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| January 10, 2020 Filed Jan 14, 2020 21:35 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 5.748 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-001557 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,272.797 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:49 UTC | NUVASIVE INC NUVA · Entity 110002 | SaleCommon Stock | 8,638 | $73.46 | $634,547.48 |
DisclosureSEC source: 0001209191-19-057474 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 202,220 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F4 · price: Weighted average sales price from sales transactions ranging from $73.28 to $73.84. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 17:49 UTC | NUVASIVE INC NUVA · Entity 110002 | SaleCommon Stock | 20,831 | $72.79 | $1,516,288.49 |
DisclosureSEC source: 0001209191-19-057474 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 210,858 F1 · shares: Sale effected pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person, which is intended to comply with Rule 10b5-1. F2 · price: Weighted average sales price from sales transactions ranging from $72.28 to $73.27. Upon request by the Commission staff, the Issuer or a security holder of the Issuer, the Reporting Person will undertake to provide full information regarding the number of shares sold at each separate price. F3 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| October 11, 2019 Filed Oct 16, 2019 20:24 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 6.167 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-030626 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,267.049 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| September 09, 2019 Filed Sep 11, 2019 12:30 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 2,000 | $51.64 | $103,280.00 |
DisclosureSEC source: 0001596783-19-000187 · wf-form4_156820500132412.xml · nonDerivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,921 F2 · balance_after: Includes restricted stock units. Read SEC document |
| September 05, 2019 Filed Sep 11, 2019 12:30 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 5,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000187 · wf-form4_156820500132412.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Family Trust Disclosed balance after: 5,068 F1 · kind: Transfer by reporting person to a revocable family trust. F3 · ownership.nature: Revocable family trust for which the reporting person serves as a trustee together with his spouse. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and these shares in this report shall not be deemed an admission of beneficial ownership of all such reported shares. Read SEC document |
| September 05, 2019 Filed Sep 11, 2019 12:30 UTC | Catalent, Inc. CTLT · Entity 16279 | GiftCommon Stock | 5,068 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000187 · wf-form4_156820500132412.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,921 F1 · kind: Transfer by reporting person to a revocable family trust. F2 · balance_after: Includes restricted stock units. Read SEC document |
| August 22, 2019 Filed Aug 26, 2019 19:49 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 3,167 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-19-000163 · wf-form4_156684897992496.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,989 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation package. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| July 12, 2019 Filed Jul 16, 2019 20:36 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 4.882 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-024628 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,260.882 F1 · shares: Represents dividends on restricted stock units (RSUs) awarded to the Reporting Person in the form of additional RSUs and are subject to the same vesting terms as the underlying awards. The dividends vest simultaneously with the RSUs to which they relate. Each RSU converts to common stock on a 1:1 basis. Read SEC document |
| May 24, 2019 Filed May 29, 2019 20:52 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | GrantCommon Stock | 3,256 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-020157 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,256 F1 · shares: This grant consists entirely of Restricted Stock Units (RSUs) that vest in full (restrictions lapse) one year from date of grant. Read SEC document |
| May 23, 2019 Filed May 23, 2019 22:14 UTC | DENTSPLY SIRONA Inc. XRAY · Entity 4448 | PurchaseCommon Stock | 10,000 | $53.60 | $536,047.00 |
DisclosureSEC source: 0001127602-19-019709 · form4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $53.52 to $53.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 22, 2019 Filed May 24, 2019 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 78,702 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032808 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 78,702 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on May 22, 2015 and is fully vested. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on May 22, 2015 and is fully vested. Read SEC document |
| May 22, 2019 Filed May 24, 2019 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 39,020 | $62.27 | $2,429,775.40 |
DisclosureSEC source: 0001209191-19-032808 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 231,689 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| May 22, 2019 Filed May 24, 2019 17:53 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 78,702 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-032808 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 270,709 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| May 09, 2019 Filed May 10, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantRSUs · Derivative | 2,577 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029056 · doc4.xml · derivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,577 Underlying: Common Stock · 2,577 shares Expires not disclosed F3 · security: Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors. F4 · derivative.expiration_date: Award of RSUs pursuant to Issuer's Board of Director's compensation policies granted under Issuer's 2014 Equity Incentive Plan. The grant will vest in full on the first to occur of (1) Issuer's 2020 Annual Meeting of Stockholders, or (2) the one-year anniversary of the date of grant. Settlement of this award has been deferred until the Reporting Person's separation from service with the Issuer's Board of Directors. Read SEC document |
| May 09, 2019 Filed May 13, 2019 17:39 UTC | Catalent, Inc. CTLT · Entity 16279 | PurchaseCommon Stock | 2,000 | $45.08 | $90,160.00 |
DisclosureSEC source: 0001596783-19-000042 · wf-form4_155776918002972.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,822 F1 · price: Volume-weighted average price. These shares were purchased in multiple transactions at prices ranging from $45.08 to $45.10, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2 · balance_after: Includes restricted stock units. Read SEC document |
| May 08, 2019 Filed May 10, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 78,702 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-029056 · doc4.xml · derivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,702 Underlying: Common Stock · 78,702 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on May 22, 2015. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's total stockholder return over the performance period ended April 30, 2019. On May 8, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 78,702 shares on May 22, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on May 22, 2015. The award was granted based on a target number of shares with a performance multiplier of 0-200% based on the Issuer's total stockholder return over the performance period ended April 30, 2019. On May 8, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 78,702 shares on May 22, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 60,010 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016800 · doc4.xml · derivative · entry 4 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 60,010 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F5 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 60,010 shares on March 1, 2019. F5 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 60,010 shares on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 19,804 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016800 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 19,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 19,804 shares on March 1, 2019. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. In accordance with the terms of the PRSU award, the award vested as to 19,804 shares on March 1, 2019. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 38,769 | $58.48 | $2,267,211.12 |
DisclosureSEC source: 0001209191-19-016800 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 192,007 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| March 01, 2019 Filed Mar 5, 2019 17:44 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 79,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-016800 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 230,776 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Read SEC document |
| February 06, 2019 Filed Feb 7, 2019 17:36 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 19,804 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008173 · doc4.xml · derivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,804 Underlying: Common Stock · 19,804 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F3 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,804 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F3 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on March 1, 2016. The award was granted based on a target number of shares with a performance multiplier of 0-250% based on the Issuer's total stockholder return over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 19,804 shares on March 1, 2019, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| February 06, 2019 Filed Feb 7, 2019 17:36 UTC | NUVASIVE INC NUVA · Entity 110002 | GrantPRSUs · Derivative | 38,527 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-008173 · doc4.xml · derivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,527 Underlying: Common Stock · 38,527 shares Expires not disclosed F1 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F2 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted with a performance condition based on the Issuer's earnings per share over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 38,527 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. F2 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on April 30, 2018. The award was granted with a performance condition based on the Issuer's earnings per share over the performance period ended December 31, 2018. On February 6, 2019, the Compensation Committee of the Issuer's Board of Directors certified the Issuer's performance for purposes of the award. Based on the Issuer's performance, the award will vest as to 38,527 shares on April 30, 2021, subject to and in accordance with the terms of the award. As the award did not constitute a derivative security, it was not required to be reported and was not reported on a Form 4 at the time of grant. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:58 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionPRSUs · Derivative | 13,997 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006915 · doc4.xml · derivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,997 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Each Performance Restricted Stock Unit ("PRSU") represents the right to receive one share of the Issuer's common stock upon vesting. F4 · derivative.exercise_date: This PRSU award was granted to the Reporting Person on May 22, 2015. In accordance with the terms of the PRSU award, the award vested as to 13,998 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 13,997 shares on February 1, 2019. F4 · derivative.expiration_date: This PRSU award was granted to the Reporting Person on May 22, 2015. In accordance with the terms of the PRSU award, the award vested as to 13,998 shares on each of February 1, 2016, February 1, 2017 and February 1, 2018 and vested as to 13,997 shares on February 1, 2019. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:58 UTC | NUVASIVE INC NUVA · Entity 110002 | Tax withholdingCommon Stock | 4,995 | $49.13 | $245,404.35 |
DisclosureSEC source: 0001209191-19-006915 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 150,962 F2 · shares: Shares withheld by the Issuer to satisfy tax withholding obligations. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Amount includes 444 shares acquired under the Issuer's employee stock purchase plan in April 2018. Read SEC document |
| February 01, 2019 Filed Feb 4, 2019 17:58 UTC | NUVASIVE INC NUVA · Entity 110002 | Exercise / conversionCommon Stock | 13,997 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-006915 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 155,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to directly receive shares pursuant to previously disclosed Company equity awards. Amount includes 444 shares acquired under the Issuer's employee stock purchase plan in April 2018. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 21:40 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 28,900 | $0.00 Strike: $4.87 | $0.00 |
DisclosureSEC source: 0001209191-18-055985 · doc4.xml · derivative · entry 5 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 28,900 shares Expires 2021-05-19 F5 · derivative.exercise_date: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 21:40 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 24,648 | $0.00 Strike: $3.15 | $0.00 |
DisclosureSEC source: 0001209191-18-055985 · doc4.xml · derivative · entry 4 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,648 shares Expires 2024-01-21 F5 · derivative.exercise_date: The option was cancelled pursuant to the Merger Agreement in exchange for an amount in cash equal to the product of (a) the excess of the Offer Price over the per-share exercise price of such option multiplied by (b) the number of unexercised shares subject to such option. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 21:40 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerCommon Stock | 18,245 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055985 · doc4.xml · nonDerivative · entry 3 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). F4 · ownership.nature: The shares are held by RiverRoad Capital Partners, LLC, of which the Reporting Person is a managing member. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 21:40 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerCommon Stock | 52,231 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055985 · doc4.xml · nonDerivative · entry 2 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · price: These securities were restricted stock units ("RSUs"), each of which represented a contingent right to receive one share of the Issuer's Common Stock. F3 · price: The RSUs were cancelled pursuant to the Merger Agreement in exchange for an amount in cash per underlying share equal to the Offer Price. Read SEC document |
| October 23, 2018 Filed Oct 23, 2018 21:40 UTC | Invuity, Inc. IVTY · Entity 162847 | Disposition to issuerCommon Stock | 99,219 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-18-055985 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,231 F1 · price: Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Stryker Corporation and Accipiter Corp., dated as of September 10, 2018 (the "Merger Agreement"), in exchange for a cash payment of $7.40 per share, without interest, subject to any required withholding of taxes (the "Offer Price"). Read SEC document |
| August 23, 2018 Filed Aug 24, 2018 18:53 UTC | Catalent, Inc. CTLT · Entity 16279 | GrantCommon Stock | 4,183 | $0.00 | $0.00 |
DisclosureSEC source: 0001596783-18-000070 · wf-form4_153513678357766.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,822 F1 · kind: The equity acquired by the reporting person is the regular, annual grant of restricted stock units provided by the Issuer to the reporting person pursuant to the Issuer's non-management director compensation program. Each restricted stock unit represents the right to receive one share of the Issuer's common stock as of the date of vesting, which will occur one year from the date of award. F2 · balance_after: Includes restricted stock units. Read SEC document |
| June 11, 2018 Filed Jun 13, 2018 23:52 UTC | Invuity, Inc. IVTY · Entity 162847 | GrantCommon Stock | 34,246 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-039935 · a4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,450 F1 · shares: Represents an automatic annual restricted stock unit (RSU) award issued pursuant to the Issuer's Outside Director Compensation Policy. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock upon settlement. 100% of the RSUs vest on June 11, 2019. The Reporting Person has elected to defer the receipt of the shares underlying the RSUs until the earlier of the Reporting Person's separation from service as a director or upon a "change of control" of the Issuer, pursuant to the Issuer's Restricted Stock Unit Deferral Program for Outside Directors. Read SEC document |
| March 16, 2018 Filed Mar 20, 2018 01:14 UTC | Invuity, Inc. IVTY · Entity 162847 | PurchaseCommon Stock | 64,158 | $3.90 | $249,921.07 |
DisclosureSEC source: 0001104659-18-018710 · a4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,204 Read SEC document |
| March 06, 2018 Filed Mar 8, 2018 17:58 UTC | NUVASIVE INC NUVA · Entity 110002 | PurchaseCommon Stock | 6,000 | $50.30 | $301,800.00 |
DisclosureSEC source: 0001209191-18-018203 · doc4.xml · nonDerivative · entry 1 LUCIER GREGORY T · CIK 0001251299 · Director · Chairman & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · Family Trust Disclosed balance after: 141,516 F1 · balance_after: Shares indirectly held by the Reporting Person. The Reporting Person also holds conditional rights to receive shares pursuant to previously disclosed Issuer equity awards. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.